Dr. Manu Hegde, MD, PhD

Dr. Hegde practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Hegde's NPI, 1124239330, was assigned on May 28, 2007. Dr. Hegde graduated from UC Davis School of Medicine in 2005. Dr. Hegde holds California license A99711.

Dr. Hegde's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Hegde's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Hegde is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hegde to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hegde practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hegde's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hegde is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Hegde is licensed in California.

Dmand AI lists epilepsy, neck pain and spine problems, non-alzheimer's dementia (chronic) and seizures among the conditions Dr. Hegde treats.

CMS data shows 427 Medicare services from Dr. Hegde across 7 procedure codes in 2024, for 202 Medicare patients. Medicare paid $41,014 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Dr. Hegde in 2024. The largest group is under 65, with 70 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hegde's median patient age at 47, with 51% women.

In 2024, Dr. Hegde wrote 1,700 Medicare Part D claims for 247 patients. 80% of them were for generic drugs. CMS names the drug for 1,516 of them, across 29 drugs with 11 or more claims each, at $829,651 in total drug cost. In 2023, CMS named 1,252 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hegde for performance year 2024, reported as part of a group. Dr. Hegde accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hegde as offering telehealth.

Dmand AI links 24 papers to Dr. Hegde, published from 2004 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Electroencephalography, Epilepsy and Seizures. Dr. Hegde has published most often in Epilepsia. Dr. Hegde's most frequent co-authors are Hooman Kamel, MD, Fredric Austin Gorin, MD and Susannah Claire Brock Cornes, MD.

Dmand AI links Dr. Hegde to 1 clinical trial. Conditions studied include Epilepsy and Brain Diseases.

CMS Open Payments shows 12 general payments to Dr. Hegde from 3 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. LivaNova USA, Inc. paid the most, $8,801.

Dmand AI lists 1 award for Dr. Hegde, most recently CMS Stage 1 EHR in 2013.

Dr. Hegde graduated from UC Davis School of Medicine in 2005. Dr. Hegde is a member of AAN.

Dr. Hegde is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.